IN2014CH00872A - - Google Patents

Download PDF

Info

Publication number
IN2014CH00872A
IN2014CH00872A IN872CH2014A IN2014CH00872A IN 2014CH00872 A IN2014CH00872 A IN 2014CH00872A IN 872CH2014 A IN872CH2014 A IN 872CH2014A IN 2014CH00872 A IN2014CH00872 A IN 2014CH00872A
Authority
IN
India
Prior art keywords
preparation
improved process
ritonavir
present disclosure
disclosure provides
Prior art date
Application number
Other languages
English (en)
Inventor
Siva Ram Prasad Vellanki
Madhu Murthy Nadella
Rajendar Reddy Mulamalla
Revathi Srinivas Ramabhotla
Original Assignee
Mylan Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Lab Ltd filed Critical Mylan Lab Ltd
Priority to IN872CH2014 priority Critical patent/IN2014CH00872A/en
Priority to PCT/IB2015/051223 priority patent/WO2015125082A1/en
Publication of IN2014CH00872A publication Critical patent/IN2014CH00872A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN872CH2014 2014-02-21 2015-02-18 IN2014CH00872A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN872CH2014 IN2014CH00872A (es) 2014-02-21 2015-02-18
PCT/IB2015/051223 WO2015125082A1 (en) 2014-02-21 2015-02-18 Improved process for the preparation of ritonavir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN872CH2014 IN2014CH00872A (es) 2014-02-21 2015-02-18

Publications (1)

Publication Number Publication Date
IN2014CH00872A true IN2014CH00872A (es) 2015-08-28

Family

ID=52693001

Family Applications (1)

Application Number Title Priority Date Filing Date
IN872CH2014 IN2014CH00872A (es) 2014-02-21 2015-02-18

Country Status (2)

Country Link
IN (1) IN2014CH00872A (es)
WO (1) WO2015125082A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5539122A (en) 1989-05-23 1996-07-23 Abbott Laboratories Retroviral protease inhibiting compounds
US5567823A (en) * 1995-06-06 1996-10-22 Abbott Laboratories Process for the preparation of an HIV protease inhibiting compound
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US6894171B1 (en) 1998-07-20 2005-05-17 Abbott Laboratories Polymorph of a pharmaceutical
US7205413B2 (en) 2002-05-03 2007-04-17 Transform Pharmaceuticals, Inc. Solvates and polymorphs of ritonavir and methods of making and using the same
US20100099885A1 (en) * 2006-10-03 2010-04-22 Mukesh Kumar Sharma Process for the preparation of form i and form ii of ritonavir

Also Published As

Publication number Publication date
WO2015125082A1 (en) 2015-08-27

Similar Documents

Publication Publication Date Title
AU2024202215A1 (en) Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12016501763A1 (en) Multispecific antibodies
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
PH12017500322A1 (en) Anti-her2 antibodies and immunoconjugates
GB2556286A (en) Programmable voltage reference
PH12016501700A1 (en) Combination therapies with anti-cd38 antibodies
PH12017501042A1 (en) Anti-cd38 antibodies for treatment of acute myeloid leukemia
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
MX2017003022A (es) Anticuerpos anti-cll-1 e inmunoconjugados.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
EP3166931A4 (en) An improved process for the preparation of enzalutamide
IN2013MU00848A (es)
MX2020007742A (es) Procesos para preparar fluorocetolidos.
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.
IN2014CH00304A (es)
NZ721832A (en) Solid forms of tenofovir
MX2017001331A (es) Composicion farmaceutica oral de isotretinoina.
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
IN2014DE00883A (es)
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
IN2014CH00872A (es)
IN2014CH01391A (es)
UA103911U (ru) Средство с вазодилатирующей активностью